1-(5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)thiourea

Catalog No.: 
ACYZMC630
CAS No.: 
51323-05-8
Molecular Formula: 
C7H5ClN4S2
Molecular Weight: 
244.73
1-(5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)thiourea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$224.00InquiryInquiry
100mg95%$326.00InquiryInquiry
250mg95%$457.00InquiryInquiry
1g95%$905.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)thiourea
IUPAC Name1-(5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)thiourea
MDL No.MFCD08063856
Molecular FormulaC7H5ClN4S2
Molecular Weight244.73
SMILESS=C(N)NC1=C(Cl)C=CC2=NSN=C21
InChI KeyHDSZYIYKDOIGFC-UHFFFAOYSA-N
Synonym(5-Chloro-2,1,3-benzothiadiazol-4-yl)-thiourea;Tizanidine EP Impurity B;Tizanidine Impurity 2(Tizanidine EP Impurity B);N-(5-Chloro-2,1,3-benzothiadiazol-4-yl)thiourea;Thiourea, N-(5-chloro-2,1,3-benzothiadiazol-4-yl)-;1-(5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)thiourea
CAS No.51323-05-8

Synthetic Route by SureRoute

1. ACYZMC630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACELDF360 route compound structure diagram
    ACELDF36030536-19-7In Stock
  4. Then
  5. ACYZMC630 route product structure diagram
    ACYZMC63051323-05-8
Inquiry

2. ACYZMC630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACELDF360 route compound structure diagram
    ACELDF36030536-19-7In Stock
  4. Then
  5. ACYZMC630 route product structure diagram
    ACYZMC63051323-05-8
Inquiry

3. ACYZMC630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYZMC630 route product structure diagram
    ACYZMC63051323-05-8
Inquiry

Comments (0)